Skip to content

EIGER BIOPHARMACEUTICALS, INC.: filings

Every EIGER BIOPHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 40 filings, each linked to its SEC index.

Filing record ends 2024-04-08

The latest filing in this captured record is a 10-K filed 2024-04-08. No later filing is in the SEC companyfacts record captured on 2026-09-22. EIGER BIOPHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2024-04-08fiscal FY 2023491000001628280-24-015297
10-Q2023-11-09fiscal Q3 2023451300001628280-23-038276
10-Q2023-08-14fiscal Q2 2023451250001628280-23-029394
10-Q2023-05-11fiscal Q1 202344910001305253-23-000011
10-K2023-03-17fiscal FY 2022501310001305253-23-000005
10-Q2022-11-03fiscal Q3 2022451310001305253-22-000008
10-Q2022-08-04fiscal Q2 2022451270001305253-22-000005
10-Q2022-05-05fiscal Q1 202246930001564590-22-018299
10-K2022-03-10fiscal FY 2021471130001564590-22-009697
10-Q2021-11-04fiscal Q3 2021421100001564590-21-054519
10-Q2021-08-05fiscal Q2 2021461220001564590-21-041599
10-Q2021-05-06fiscal Q1 202147890001564590-21-025012
10-K2021-03-09fiscal FY 2020421050001564590-21-011758
10-Q2020-11-05fiscal Q3 2020371020001564590-20-051341
10-Q2020-08-06fiscal Q2 202037980001564590-20-037833
10-Q2020-05-07fiscal Q1 202036730001564590-20-022884
10-K2020-03-13fiscal FY 2019411000001564590-20-010645
10-Q2019-11-07fiscal Q3 2019371000001564590-19-041773
10-Q2019-08-08fiscal Q2 201937950001564590-19-030837
10-Q2019-05-09fiscal Q1 201936700001564590-19-018009
10-K2019-03-14fiscal FY 201838970001564590-19-007830
10-Q2018-11-09fiscal Q3 201833840001564590-18-028934
10-Q2018-08-10fiscal Q2 201831800001564590-18-021197
10-Q2018-05-11fiscal Q1 201827520001564590-18-013225
10-K2018-03-09fiscal FY 201730760001564590-18-005123
10-Q2017-11-09fiscal Q3 201726710001564590-17-023294
10-Q2017-08-11fiscal Q2 201726710001564590-17-017417
10-Q2017-05-12fiscal Q1 201726530001564590-17-010695
10-K2017-03-23fiscal FY 201632750001564590-17-005079
10-Q2016-11-08fiscal Q3 201625630001564590-16-028120
10-Q2016-08-10fiscal Q2 201626650001564590-16-023923
10-Q2016-05-16fiscal Q1 201624470001193125-16-591622
10-K2016-03-30fiscal FY 201529900001193125-16-523887
10-Q2015-11-09fiscal Q3 201525670001193125-15-372092
10-Q2015-08-11fiscal Q2 201525660001193125-15-286510
10-Q2015-05-15fiscal Q1 201525520001193125-15-188536
10-K2015-03-31fiscal FY 201430910001193125-15-112793
10-Q2014-11-12fiscal Q3 201426690001193125-14-407683
10-Q2014-08-07fiscal Q2 201425800001193125-14-298882
10-Q2014-05-13fiscal Q1 201425630001193125-14-197051

Inspect the source

Entity
EIGER BIOPHARMACEUTICALS, INC. / CIK 0001305253
Captured
SEC response SHA-256
15a4e18e5e12f9c28504a85f9db33ce53ce847f38e5ccf78a6e837039b23f34a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001305253.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))